Overview

The theme of my research is High resolution, multi-omic network biology. My lab uses high resolution (single cell RNA-seq, spatial transcriptomics), multi-omic (transcriptomics, metabolomics, and epigenomics) and biological networks (signaling networks, metabolic networks) to address a wide range problems in stem cell biology, cancer and aging.

1. Catching the wisphers in single cell transcriptomics

I recently developed a method called talklr (intercellular crossTALK using Ligand-Receptor), which uses Kullback-Leibler divergence, a concept from inforamtion theory, to uncover interesting ligand-receptor interactions among multiple cell types in single cell RNA-seq data. talklr can automatically detect ligand-receptor pairs mediating one-to-many or many-to-many cell-cell interactions. It also uncovers interesting ligand-receptor re-wiring between two conditions (e.g., disease vs. healthy, young vs. old).

2. Genome-scale metabolic network modeling of the tumor microenvironment

Spatially resolved transcriptomics data is increasingly used to profile many diseases (e.g., prostate cancer, breast cancer, melanoma, prostate cancer, ALS) and developmental processes (e.g., embryogenesis, heart development). We developed a new computational pipeline that uses the mCADRE method I previously developed to build spatially-resolved metabolic network models of the prostate cancer microenvironment. We identified novel selective metabolic targets that would otherwise be missed by models built from bulk transcriptomics data.

3. Using scRNA-seq to identify maturation signatures of pluripotent stem cell derived cardiomyocytes (PSC-CM)

My collaborators at ISCRM developed a microRNA cocktail to accelerate the maturation of PSC-CM. I performed scRNA-seq analysis of PSC-CM with different microRNA over-expression/knock-out combinations to determine which ones are driving the maturation process. We evaluated our discovery against publicly available bulk and single cell RNA-seq of human & mouse heart development. I also used trajectory analysis to uncover an interesting subset of proliferating PSC-CMs that emerged after knocking out a key component of the mitochondria fatty acid oxidation machinery. This mimics the genetic defects in sudden infant deaths. Our collaborators succesfully identified a small molecule that mitigate this defect in vitro.